Banking on it: Public policy and the ethics of stem cell research and development

Social Science and Medicine

Volumn 65, Issue 7, 2007, Pages 1490-1500

  Giacomini, Mita ^a   Baylis, Francoise ^b   Robert, Jason ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Bioethics; Ethics; Health policy; Resource allocation; Social values; Stem cells; Tissue sharing

Indexed keywords

CELL ORGANELLE; DEMOGRAPHY; DISEASE TRANSMISSION; ETHICS; HEALTH CARE; HEALTH POLICY; HEALTH RISK; RESOURCE ALLOCATION;

ARTICLE; CELL MATURATION; CORD BLOOD STEM CELL TRANSPLANTATION; COST BENEFIT ANALYSIS; ETHICS; HEALTH CARE SYSTEM; HUMAN; IN VITRO STUDY; MEDICAL RESEARCH; POLICY; STEM CELL; UMBILICAL CORD BLOOD;

BIOETHICS; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYO RESEARCH; EMBRYONIC STEM CELLS; ETHICAL ANALYSIS; ETHICS, RESEARCH; HUMANS; PUBLIC POLICY; RESOURCE ALLOCATION; SOCIAL JUSTICE; SOCIAL WELFARE; STEM CELL TRANSPLANTATION; TISSUE AND ORGAN HARVESTING; TISSUE BANKS;

EID: 34548209918     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2007.05.021     Document Type: Article

References (30)

1. Adams P., Cohen D., Danovitch G., Edington R., Gaston R., Jacobs C., et al. The nondirected live-kidney donor: Ethical considerations and practice guidelines: A national conference report. Transplantation 74 4 (2002) 582-589
2. Alison M., Poulsom R., Otto W., Vig P., Brittan M., Direkze N., et al. Plastic adult stem cells: Will they graduate from the school of hard knocks?. Journal of Cell Science 116 (2003) 599-603
3. Baylis F., and Downie J. An embryonic debate. Literary Review of Canada 13 2 (2005) 11-13
4. Brinton L., Lamb E., Moghissi K., Scoccia B., Althuis M., Mabie J., et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstetrics and Gynecology 103 (2004) 1194-1203
5. Callahan D. How much medical progress can we afford? Equity and the cost of health care. Journal of Molecular Biology 319 4 (2002) 885-890
6. Dawson L., Bateman-House A.S., Agnew D.M., Bok H., Brock D.W., Chakravarti A., et al. Safety issues in cell-based intervention trials. Fertility and Sterility 80 5 (2003) 1077-1085
7. Faden R.R., Dawson L., Bateman-House A.S., Agnew D.M., Bok H., Brock D.W., et al. Considerations of justice in stem cell research and therapy. Hastings Center Report (Nov-Dec) 13-27 (2003)
8. Greene M. To restore faith and trust: Justice and biological access to cellular therapies. Hastings Center Report Jan-Feb 57-63 (2006)
9. Guston D., and Sarewitz D. Real-time technology assessment. Technology in Society 24 (2002) 93-109
10. Inhorn M., and Fakih M. Arab Americans, African Americans, and infertility: Barriers to reproduction and medical care. Fertility and Sterility 85 4 (2006) 844-852
11. Kimmelman J., Baylis F., and Glass K.C. Stem cell trials: lessons from gene transfer research. Hastings Center Report 36 1 (2006) 23-26
12. Lakshmipathy U., and Verfaillie C. Stem cell plasticity. Blood Reviews 19 (2005) 29-38
13. Lifebank (2004). Banking and storage fees. 〈http://www.lifebank.com/register/fees.asp〉, update version not provided [accessed 23 November 2004].
14. Lo B., Zettler P., Cedars M.I., Gates E., Kriegstein A., Oberman M., et al. A new era in the ethics of human embryonic stem cell research. Stem Cells 23 (2005) 1454-1459
15. Medicetty S., Bledsoe A., Fahrenholtz C., Troyer D., and Weiss M. Transplantation of pig stem cells into rat brain: Proliferation during the first 8 weeks. Experimental Neurology 190 (2004) 32-41
16. Moore B., and Quesenberry P. The adult hemopoietic stem cell plasticity debate: Idols vs new paradigms. Leukemia 17 (2003) 1205-1210
17. Pearson H. Health effects of egg donation may take decades to emerge. Nature 442 (2006) 607-608
18. Robert J. Model systems in stem cell biology. BioEssays 26 (2004) 1005-1012
19. Roberts J., Wolfe R., Bragg-Gresham J., Rush S., Wynn J., Distant D., et al. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. New England Journal of Medicine 350 6 (2004) 545-551
20. Rossing M., Darling J., Weiss N., Moore D., and Self S. Ovarian tumors in a cohort of infertile women. New England Journal of Medicine 331 12 (1994) 771-776
21. Statistics Canada (2004). CANSIM Table 051-0004. 〈http://www.statcan.ca/english/Pgdb/demo33a.htm〉, update version of 21 October 2004 [accessed 23 November 2004].
22. Taylor C., Bolton E., Pocock S., Sharples L., Pedersen R., and Bradley J. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 366 Dec 10 (9502) (2005) 2019-2025
23. Testa G., and Harris J. Ethics and synthetic gametes. Bioethics 19 2 (2005) 146-166
24. The Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertility and Sterility 80 5 (2003) 1309-1314
25. The President's Council on Bioethics. Monitoring stem cell research (2004), The President's Council on Bioethics, Washington, DC
26. Thomson, J. (1998). Statement, Hearings before a subcommittee of the Committee on Appropriations United States Senate. Washington, DC.
27. Vogel G. Stem cells. Scientists chase after immortality in a petri dish. Science 309 5743 (2005) 5743
28. Weiss M., Mitchell K., Hix J., Medicetty S., El-Zarkouny S., Grieger D., et al. Transplantation of porcine umbilical cord matrix cells into the rat brain. Experimental Neurology 182 2003 (2003) 288-299
29. Weissman I. Medicine: Politic stem cells. Nature 439 7073 (2006) 145-147
30. Wolfe R., Ashby V., Milford E., Bloembergen W., Agodoa L., Held P., et al. Differences in access to cadaveric renal transplantation in the United States. American Journal of Kidney Diseases 36 5 (2000) 1025-1033